Delving into the Latest Updates on Monovalent Influenza A/Astrakhan/3212/2020 Like (H5N8) Virus Vaccine(GlaxoSmithKline) with Synapse

Overview

Basic Info

Drug Type

Prophylactic vaccine

Synonyms-

Target-

Action

stimulants

Mechanism

Immunostimulants

Therapeutic Areas

Infectious DiseasesRespiratory Diseases

Active Indication

Influenza A virus infection

Inactive Indication-

Originator Organization

GSK Plc

Active Organization

GSK Plc

Inactive Organization-

License Organization-

Drug Highest PhasePhase 1/2

First Approval Date-

Regulation-

Login to view timeline

A Phase I/II Observer-blind, Randomized, Multi-center Trial to Evaluate the Safety and Immunogenicity of Different Formulations of Monovalent Influenza A/Astrakhan/3212/2020 Like (H5N8) Virus Vaccine With AS03 Adjuvant System (Referred to as Q-Pan H5N8), Given as a Two-dose Series to Adults 18 to 64 Years of Age and 65 Years of Age and Older

The purpose of this study is to assess the safety and immunogenicity of different formulations of monovalent Influenza A/Astrakhan/3212/2020-like virus vaccine with AS03 adjuvant system in adults greater than or equal to (>=)18 years of age.

Start Date03 Aug 2023

Sponsor / Collaborator

GSK Plc

NCT02415842

/ CompletedNot Applicable

An Exploratory, Retrospective Laboratory Evaluation of the Humoral Immune Response in Adults and Children to the H1 HA Stalk Domain and Other Influenza A Virus Protein Epitopes, After Administration of GSK Biologicals' Pandemic Influenza Vaccines

The purpose of this exploratory, retrospective laboratory study is to assess the humoral immune response to H1 hemagglutinin stalk domain and other influenza A virus protein epitopes following administration, in adults and children, of GSK Biologicals' adjuvanted and unadjuvanted pandemic influenza vaccines, using archived serum samples from previously completed clinical trials.

Start Date26 Oct 2015

Sponsor / Collaborator

GSK Plc

[+1]

100 Clinical Results associated with Monovalent Influenza A/Astrakhan/3212/2020 Like (H5N8) Virus Vaccine(GlaxoSmithKline)

Login to view more data

100 Translational Medicine associated with Monovalent Influenza A/Astrakhan/3212/2020 Like (H5N8) Virus Vaccine(GlaxoSmithKline)

Login to view more data

100 Patents (Medical) associated with Monovalent Influenza A/Astrakhan/3212/2020 Like (H5N8) Virus Vaccine(GlaxoSmithKline)

Login to view more data

100 Deals associated with Monovalent Influenza A/Astrakhan/3212/2020 Like (H5N8) Virus Vaccine(GlaxoSmithKline)

Login to view more data